Notice concerning the shorter shelf-life of Act-HIB, vaccine against Haemophilus influenzae type B, Vaccinum haemophili stirpe b coniugatum, Lot D0636-3
In collaboration with the Agency for Medicinal Products and Medical Devices, on 31 May 2010, Medoka d.o.o. sent a notice to the Croatian National Institute of Public Health, all County Institutes of Public Health, Institute of Immunology (warehousing and distribution of vaccines from the Vaccination Programme) and vaccinators, advising them of the shorter shelf life of Act-HIB, vaccine against Haemophilus influenzae type b, Lot: D0636-3.
The packaging of the above vaccine lot reads Expiry Date June 2011. The Agency, when issuing the Special Quality Control Certificate, shortened the shelf life to 31.12.2010. due to a discrepancy in the respective expiry dates of the finished medicinal product and the enclosed solvent, since the enclosed solvent has an expiry date of December 2010.
Consequently, the vaccine must not be used after 31.12.2010.
The text of the letter can be found below (available in Croatian):
Notice concerning the shorter shelf-life of Act-HIB, vaccine against Haemophilus influenzae type b, Lot D0636-3